abstract |
The present invention relates to 18-methyl-6,7-methylene-17-pregn-4-ene-21,17β-carbolactones of the general formula (I) where the 6,7-methylene group may be in the α or β position, to pharmaceutical preparations comprising at least one isomer of the formula (I) and to the use thereof in the treatment of endometriosis. |